|Podcasts|May 21, 2021
Episode 37: The Impact of Awareness Efforts in ALS
Author(s)Matt Hoffman
"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Matthew B. Harms, MD.
Advertisement
Episode 37 of the NeurologyLive Mind Moments podcast is now live! Scroll down to listen or click here to subscribe on your favorite streaming service.
The Mind Moments podcast features exclusive interviews with leaders in the field discussing the latest research and disease management strategies across the breadth of neurology, including epilepsy, multiple sclerosis, Parkinson disease, dementia, sleep disorders, and more.
Episode 37, "The Impact of Awareness Efforts in ALS," features an interview with Matthew B. Harms, MD, associate professor of neurology, Columbia University, and medical consultant and care center director, Muscular Dystrophy Association. In honor of May as ALS Awareness Month, he detailed the impact that awareness efforts have had on improving patient care, how informed the patient population is about the ongoing developments, and some of the latest research and advances that have been made in amyotrophic lateral sclerosis.
EPISODE BREAKDOWN
1:15 – The impact of the ALS Ice Bucket Challenge on research and funding
5:30 – "Big Data" in ALS research and care
8:30 – Current potential in the pipeline and the informed patient population
10:50 – Patient education efforts in ALS
13:05 – Takeaways for the clinical community during ALS Awareness Month
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Articles
- This Week on NeurologyLive® — September 15, 2025
September 15th 2025
- NeurologyLive® Brain Games: September 14, 2025
September 14th 2025
- NeurologyLive® Friday 5 — September 12, 2025
September 12th 2025
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive
1
MDA and PPMD Release Consensus Guidelines for Safe and Equitable Use of Gene Therapy in Duchenne
2
10 Years of the Women Neurologists Group: A Preview of the 4th Annual Conference
3
DORAs Carry Lower Real-World Abuse, New Phase 3 Argus Data, RAP-219 Meets Primary End Point
4